Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Jacob

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Blood|May 16, 1998
Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.
Immunology Letters|February 1, 1991
Impaired clonogenic potential of CD25 positive T cells in lymph nodes involved by B cell non-Hodgkin's lymphomasT Bonnefoix, E Claret, M P Piccinni, et al.
British Journal of Haematology|June 1, 1990
Variant t(2;18) translocation in a follicular lymphomaD Leroux, M Monteil, J J Sotto, et al.
Genes, Chromosomes & Cancer|May 1, 1991
t(18;22)(q21;q11) with rearrangement of BCL2 as a possible secondary change in a lymphocytic lymphomaD Leroux, J Hillion, M Monteil, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and bloodF Garban, M Gallagher, E Jouvin-Marche, et al.
British Journal of Haematology|April 1, 1990
Production of granulopoiesis-stimulating and -inhibiting activities by T cells associated with malignant cells in lymphomasM P Piccinni, M C Jacob, T Bonnefoix, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology|January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)M C Jacob, M Favre, F Lemarc'Hadour, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Leukemia|February 24, 2001
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell lineM Irisarri, J Plumas, T Bonnefoix, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Blood|May 16, 1998
Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosisJ Plumas, M C Jacob, L Chaperot, et al.
Immunology Letters|February 1, 1991
Impaired clonogenic potential of CD25 positive T cells in lymph nodes involved by B cell non-Hodgkin's lymphomasT Bonnefoix, E Claret, M P Piccinni, et al.
British Journal of Haematology|June 1, 1990
Variant t(2;18) translocation in a follicular lymphomaD Leroux, M Monteil, J J Sotto, et al.
Genes, Chromosomes & Cancer|May 1, 1991
t(18;22)(q21;q11) with rearrangement of BCL2 as a possible secondary change in a lymphocytic lymphomaD Leroux, J Hillion, M Monteil, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Immunotherapy by non-myeloablative stem cell transplantation: study of the immune reconstitution. Arguments for distinct cell subsets in skin and bloodF Garban, M Gallagher, E Jouvin-Marche, et al.
British Journal of Haematology|April 1, 1990
Production of granulopoiesis-stimulating and -inhibiting activities by T cells associated with malignant cells in lymphomasM P Piccinni, M C Jacob, T Bonnefoix, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology|January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)M C Jacob, M Favre, F Lemarc'Hadour, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Leukemia|February 24, 2001
Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell lineM Irisarri, J Plumas, T Bonnefoix, et al.
Pageof 7